FR2720935A1 - Poudres à base de métoclopramide et d'acétylsalicylate de lysine pour solutions injectables. - Google Patents

Poudres à base de métoclopramide et d'acétylsalicylate de lysine pour solutions injectables. Download PDF

Info

Publication number
FR2720935A1
FR2720935A1 FR9407019A FR9407019A FR2720935A1 FR 2720935 A1 FR2720935 A1 FR 2720935A1 FR 9407019 A FR9407019 A FR 9407019A FR 9407019 A FR9407019 A FR 9407019A FR 2720935 A1 FR2720935 A1 FR 2720935A1
Authority
FR
France
Prior art keywords
metoclopramide
powder
monohydrochloride
unit dose
equivalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9407019A
Other languages
English (en)
French (fr)
Other versions
FR2720935B1 (ja
Inventor
Thierry Depauw
Raymond Senequier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9407019A priority Critical patent/FR2720935A1/fr
Publication of FR2720935A1 publication Critical patent/FR2720935A1/fr
Application granted granted Critical
Publication of FR2720935B1 publication Critical patent/FR2720935B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9407019A 1994-06-08 1994-06-08 Poudres à base de métoclopramide et d'acétylsalicylate de lysine pour solutions injectables. Granted FR2720935A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9407019A FR2720935A1 (fr) 1994-06-08 1994-06-08 Poudres à base de métoclopramide et d'acétylsalicylate de lysine pour solutions injectables.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9407019A FR2720935A1 (fr) 1994-06-08 1994-06-08 Poudres à base de métoclopramide et d'acétylsalicylate de lysine pour solutions injectables.

Publications (2)

Publication Number Publication Date
FR2720935A1 true FR2720935A1 (fr) 1995-12-15
FR2720935B1 FR2720935B1 (ja) 1997-02-14

Family

ID=9464005

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9407019A Granted FR2720935A1 (fr) 1994-06-08 1994-06-08 Poudres à base de métoclopramide et d'acétylsalicylate de lysine pour solutions injectables.

Country Status (1)

Country Link
FR (1) FR2720935A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105342997A (zh) * 2015-11-28 2016-02-24 山东齐都药业有限公司 一种盐酸甲氧氯普胺注射液及其制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Vidal", 1992, EDITIONS DU VIDAL, PARIS, 18969 *
PLON M.: "MIGRAINE: APPROCHES MULTIFOCALES", GAZ. MED. (FRANCE), 1993, VOL. 100, NO. 25, PAGE(S) 33-34, *
SCHWOB; LASSNER: "TRAITEMENT DE LA CRISE AIGUE DE MIGRAINE PAR L'ASSOCIATION ACETYLSALICYLATE DE LYSINE METOCLOPRAMIDE", GAZ. MED. FR. (FRANCE), 1983, VOL. 90, NO. 7, PAGE(S) 625-628, *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105342997A (zh) * 2015-11-28 2016-02-24 山东齐都药业有限公司 一种盐酸甲氧氯普胺注射液及其制备方法
CN105342997B (zh) * 2015-11-28 2018-10-16 山东齐都药业有限公司 一种盐酸甲氧氯普胺注射液及其制备方法

Also Published As

Publication number Publication date
FR2720935B1 (ja) 1997-02-14

Similar Documents

Publication Publication Date Title
US5719122A (en) Pharmaceutical compositions containing a calcitonin
ES2657484T3 (es) Agentes de administración de ácido fenilalquilcarboxílico
EP0321516A1 (en) 3-INDOLEPYRUVIC ACID DERIVATIVES AND PHARMACEUTICAL USE THEREOF.
DE3774449D1 (de) Pharmazeutische zusammensetzungen.
KR100851679B1 (ko) 2-(4-이소부틸페닐)프로피온산의 약학 조성물
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
ES2208907T3 (es) Antibiotico a base de carbapenem, composicion y procedimiento de preparacion.
FI913949A0 (fi) Menetelmä substituoidun karboksyylihapon farmaseuttisesti käyttökelpoisen kodeiinisuolan valmistamiseksi
BE899564A (fr) Composition pharmaceutique pour l'administration parenterale a base de nimodipin et procede pour sa preparation.
IL97796A0 (en) Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation
KR890004694A (ko) 약리학적 활성 화합물과 약학적 부형제를 위한 용해제로서의 수용성 모노 에스테르
US4406896A (en) Adjuvants for rectal delivery of drug substances
EP0031561B1 (en) A rectally administered suppository comprising a drug and an adjuvant
FR2720935A1 (fr) Poudres à base de métoclopramide et d'acétylsalicylate de lysine pour solutions injectables.
FR2358159A1 (fr) Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
FR2558060A1 (fr) Nouvelles formes pharmaceutiques contenant des diphosphonates
JPH1045599A (ja) 経皮的使用のためのアセチルサリチル酸含有アルコール性溶液、抗血栓治療のためのその利用及び薬剤
EP0695546A1 (fr) Poudres à base de métoclopramide et de paracétamol ou de dérivés d'acide acétylsalicyclique
JPH0717500B2 (ja) 1,4−ジヒドロキシ−5,8−ビス〔2−(2−ヒドロキシエチルアミノ)−エチルアミノ〕アントラキノン二塩酸塩の安定な注射用医薬配合物
FR2515516B1 (fr) Composition pharmaceutique pour le traitement de la lithiase renale infectee contenant de l'acide propionohydroxamique ou ses sels acceptables en pharmacie
JP2812683B2 (ja) 持続性を有するモルヒネ直腸投与製剤
FR2535205A1 (fr) Solution pour injection a base de substances antirhumatismales et d'une cobalamine et procede pour sa preparation
EP0063773A1 (en) Orally active tolciclate and tolnaftate
FR2387035A1 (fr) Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
FR2374035A1 (fr) Nouvelle composition pharmaceutique pour le traitement de troubles cardio-vasculaires

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20060228